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ABSTRACT
BACKGROUND: Association between chlamydia trachomatis infection and male infertility is debated in 
literature. There is little or no information from Nigeria. The study aimed to determine the prevalence of 
chlamydial infection and its association with sperm quality parameters among asymptomatic men that 
present for infertility treatment in a Nigeria facility.
METHODS: A cross-sectional study conducted at a private assisted conception clinic in Lagos, Nigeria among 
138 men seeking infertility care. Seminal fluid analysis and IgG Chlamydial serology were performed for each 
participant. Data obtained were analysed using SPSS; p was significant at <0.05.
RESULTS: Of the 138 men screened, 13.9% were Chlamydia-positive. Twenty-one per cent of clients who 
tested positive to Chlamydia had predominantly immotile sperm, compared with 10.2% without the infection; 
26.3% with non-progressive motility had Chlamydia, compared with 2.8% men who were not infected. These 
differences were statistically significant (p = 0.001).  More of those (57.9%) with Chlamydia (compared to 
33.1% without) had significant leukocyte counts (p = 0.037). There were no statistically significant differences 
in sperm count and percent motility between serologically positive and negative men.
CONCLUSION: Positive Chlamydia serology is associated with non-progressive motility and 
leukocytospermia in infertile Nigerian men. 
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INTRODUCTION
exually transmitted infection (STI) is the 
Scommonest aetiological factor for infertility in developing countries. Its impact is made 
worse on account of poor diagnostic capability, 
indiscriminate antibiotic use, higher levels of 
risky sexual behaviour and poor health-seeking 
1, 2behaviour of aficted individuals.  Chlamydia is 
1
the commonest bacterial cause of STI worldwide  
and paradoxically, individuals infected are often 
unaware because of its asymptomatic progression 
1,2
in most cases.  Studies have shown that most 
3,4 infected men and women are asymptomatic.
Chlamydia trachomatis (CT) is commonly 
assoc ia ted  with  both  upper  and lower 
reproductive tract infections with evidence of 
progression to tubal infertility in women when it 
2is poorly treated.  Regarding the choice of 
appropriate screening methods, there has been a 
systematic improvement in the quality and 
accuracy of techniques used over the years 
especially in the industrialized countries. There 
are a number of laboratory tests to detect CT to 
different degrees of certainty. They include: 
antigen detection in the form of enzyme 
immunoassay, direct immunouorescence assay 
and nucleic acid amplication tests; secondly, the 
molecular tests detect either DNA or RNA using 
PCR; and lastly the serological tests use 
immunoglobulin markers of CT such as IgA and 
2, 5, 6
or IgG.   
Male infertility investigation has witnessed 
conicting recommendations for routine 
41
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screening of CT infection during the evaluation 
phase of infertility management because of the 
controversial evidence from literature. Some 
studies conclude that positive CT infection 
markers are not associated with abnormal sperm 
 7 ,8parameters , whereas others have suggested that 
there is high correlation with abnormal sperm 
motility, lower density, and reduced viability and 
9,10
morphology . Another argument for male 
screening is that men are believed to be the 
11reservoir of CT infection for females . The debate 
has made a universal call for CT screening among 
men seeking infertility a bit challenging and 
presently, the screening is often context-based .
In Nigeria, the commonest cause of infertility 
among couples seeking treatment is still infection-
related and local studies mostly focus attention at 
unravelling the causation among women rather 
than their male partners . Chlamydial infection 
screening studies among infertile couple have 
been largely restricted to women, using different 
study designs and outcomes . Usually, these 
studies use their results as proxies in either 
descr ibing or  est imating the  burden of 
15Chlamydial infection among males.  The usual 
pattern has been indirect treatment of men 
suspected to have CT through partner notication 
methods. 
Men in Nigeria are often not forthcoming in 
seeking infertility treatment due to the socio-
cultural stereotype that feminizes infertility. 
However, the reality is that male factor contributes 
a sizeable proportion of the aetiology. This gap has 
made objective assessment of CT infection burden 
herculean, and made its consequential impact on 
sperm quality among men seeking infertility 
treatment unknown. It is against this backdrop 
that we aimed to study the prevalence of CT 
infection and its association with sperm quality 
parameters among men without cl inical 
symptoms that present for infertility treatment.
Materials and Methods
This was a cross-sectional study conducted among 
men seeking infertility treatment with their female 
partners at Nordica Fertility Centre, Lagos, 
Nigeria. The study area is a privately-owned 
assisted conception centre which offers a wide 
range of assisted reproductive services to 
Nigerians and other nationals from the West 
African sub-region. Couples desiring fertility 
treatment are referred, while others present on 
their own after failed attempts at conventional 
care for infertility. All patients that present for 
fertility treatment at the study centre undergo an 
initial counselling session to familiarize them 
with the treatment protocols and thereafter, pre-
treatment evaluation is offered to the couple. This 
includes serological screening for CT infection 
and seminal uid analysis. 
The study subjects were men at this clinic who 
were counselled for and consented to the use of 
their seminal uid analysis and Chlamydia 
screening results for this study. These men were 
being evaluated as part of the routine care offered 
by the clinic and gave written consent to 
participate in the study and for their laboratory 
results to be analysed. They were assured that 
refusal to participate would not affect their care in 
any way. 
Those with clinical evidence of STI or who had 
had antibiotic treatment in the preceding two 
weeks were excluded. The null hypothesis was 
that there is no association between Chlamydial 
infection in infertile men and abnormal sperm 
parameters .  Minimum sample s ize was 
determined to be 73 with a formula for cross-
16 17
sectional studies , using a prevalence of 5%.  A 
convenience sampling method of consecutive 
consenting patients was employed.
Blood samples were collected for the serological 
examination. Semen samples were collected by 
masturbation. Seminal uid analysis was 
performed in the laboratory within an hour of the 
collection. The men were counselled to avoid 
sexual activity 3 to 5 days prior to the collection of 
semen. The semen was prepared, and the analysis 
18
reported according to standard criteria. A total of 
138 consenting men were reported in this study.
Chlamydia serology: Five millilitres of venous 
blood was collected into a universal bottle and the 
serum separated by centrifuging the clotted 
sample. The serological assay for Chlamydia 
antibody (IgG) testing was performed using an 
automated kit for multi-serovar for CT species, 
® 
Immunocomb Chlamydia Bivalent IgG kit 
(Orgenics Ltd., Yavne, Israel), which employs an 
indirect solid phase enzyme immunoassay 
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technique. Prior to each test, the reagent was 
allowed to stand till it was at room temperature. 
Pipette samples of the sera were assayed with the 
reagent's control samples for CT antibodies. This 
process passed through different stages as 
specied by the manufacturer with strict timing 
schedule. Thereafter, the result was read with the 
aid of colorimeter calibration and this was 
compared with the control sample. A CT 
serological result was deemed positive when the 
titre was at least 1 in 16 or more.
Data analysis was performed with SPSS. 
Descriptive analysis of pattern of sperm 
parameters and Chlamydia serology were 
performed and thereafter, cross tabulations 
between seminal uid analysis results and CT 
serological outcomes were also performed using 
chi-square test. The level of statistical signicance 
was set at p < 0.05.
Ethics
All procedures followed were according to the 
Declaration of Helsinki.  Approval was given by 
the study Centre's review committee.
RESULTS
Of the 138 men that presented with infertility, 19 
(13.9%) were positive for Chlamydial antibody. 
The sperm quality of the 138 men studied is shown 
in Table 1. In terms of sperm count, 64 (46.3%) 
subjects had varying degrees of reduced or absent 
counts. Thirty-ve (15.1%) had less than 30% 
motility while only thirty-six men (28.6%) had at 
least 50% motility. 
For sperm count, 5 men (26.3%) positive to 
Chlamydia had severe oligozoospermia 
compared to 9 (7.6%) that were Chlamydia 
negative. Similarly, a higher proportion of men 
(55.1%) without Chlamydia had normal sperm 
count compared with those who were infected 
(42.1%). However, the differences in these 
proportions were not statistically signicant (p = 
0.092).
Among those with above 50% motility, thirty-two 
(30.2%) were Chlamydia negative while four 
(22.2%) were positive. Similar proportions of 
Chlamydia positive and negative men had 
percent motility between 30% and <50%. There 
was no statistically signicant difference between 
the percent motility of those with and without 
Chlamydia infection (p = 0.145).
A signicantly higher proportion of men without 
Chlamydia (66.9%) compared to 42.1% with 
Chlamydia had normal leukocyte counts while 
more of those with the infection (57.9%) had 
signicant leukocyte counts (p = 0.037).
DISCUSSION
In the index study, it was observed that 13.9% of 
men seeking infertility treatment were positive 
for Chlamydial infection even though they did 
not demonstrate any clinical features. Reported 
prevalence in literature (diagnosed from 
17,19
antibody) varies from 5% to 21.7%. Over half of 
the study participants had good sperm quality. 
There was a signicant difference in sperm 
quality results between those with positive and 
negative Chlamydial serology. There was a 
higher proportion of non-progressive motility 
and leukocytospermia among Chlamydia-
positive men compared to those who were 
negative. These ndings corroborated previous 
reports that positive Chlamydial serology may be 
19,20
associated with abnormal sperm quality.   The 
association of leukocytospermia with poor sperm 
function, and therefore, infertility has been 
21,22demonstrated. 
The association between Chlamydial serologic 
test and sperm quality appears controversial due 
to mixed results, and this has made other methods 
23
preferable, such as antigen and DNA testing.  
Serology does not indicate the difference between 
recent or previous infection; and its value for male 
                










































Non-progressive motility 5(26.3) 3(2.8)
Progressive motility 10(52.6) 94(87.0) 
Percent motility*
<30% 4 (22.2) 15 (14.2) 0.99 0.609
>30% and <50% 10 (55.6) 59 (55.7)
> 50% 4 (22.2) 32 (30.2)
WBC 
 
    
  
















     
*Totals do not include the azoospermic samples
** Fisher's exact correction used with cells <5
Table 1: Prole of Sperm Quality
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infertility workup may be limited.  Despite these 
aws, serological test for CT is highly sensitive, 
and a positive result is an indication for a clinician 
to pay attention to the sexual history of the patient. 
This could provide a clue to the aetiology, and the 
method of infertility treatment that best suits the 
situation. Furthermore, the challenge prevalent in 
the management of men by proxy in developing 
countries (that is, from their partner's CT infection 
report) can easily be resolved with this simple test.
This study therefore highlights a critical aspect of 
male infertility evaluation that is often neglected 
in the developing countries, and adds to the sparse 
body of data on male infertility in Nigeria. The use 
of serology may be limited, yet it is by far better 
than opting for 'therapeutic guessing' in offering 
treatment to men, which may not have any 
scientic rationale. At the same time, efforts 
should be made to make a more specic test such 
as antigen and/or DNA test available and 
accessible in our setting. 
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